With fibromyalgia, you may have a lower threshold for pain. Experts believe this may result from changes in your nervous system. These changes may cause you to be more sensitive to pain. This could ...

CHICAGO -- Patients diagnosed with fibromyalgia who remain on therapy can achieve long-term pain relief -- to at least three years -- from treatment with the selective serotonin and norepinephrine ...

Savella, a newly approved treatment for fibromyalgia, will be hitting U.S. pharmacy shelves in March and likely will be facing some stiff competition. But the companies that will market Savella, ...

Details concerning the Milnacipran hcl (Savella) medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, ...

SAVELLA (Milnacipran) 12.5mg, 25mg, 50mg, 100mg tablets by Forest and Cypress Forest Laboratories and Cypress Bioscience received FDA approval for Savella (milnacipran HCl), a selective serotonin and ...

Glenmark will have the option to market and distribute its milnacipran hydrochloride tablets or an authorised generic version of Savella tablets Glenmark Pharmaceuticals announced a patent litigation ...

Aug 5 (Reuters) - Hedge fund Ramius, which had offered to buy drugmaker Cypress Bioscience Inc in July, said it has sent a letter to Cypress' board objecting to the company's decision to discontinue ...

Says to get $2 mln from Forest To cut 123 jobs To take charges of about $4.5 mln Aug 4 (Reuters) - Cypress Bioscience Inc said it is discontinuing its right to co-promote fibromyalgia drug Savella ...